<DOC>
	<DOC>NCT02029144</DOC>
	<brief_summary>Dydrogesterone has been widely used worldwide for various gynecological and obstetric indications: - Dydrogesterone is effective in cycle regulation treatment. - Dydrogesterone is recognized as none interference to hypothalamus pituitary ovary (HPO) axis in the recommended dosage. - Dydrogesterone might have non-negative effect on glucose and lipid metabolic.</brief_summary>
	<brief_title>Observational Study of Dydrogesterone in Cycle Regularization</brief_title>
	<detailed_description>The current study is designed as a prospective, non-interventional, observational study. Patients with irregular cycle diagnosed as AUB-O will be prescribed dydrogesterone as per physician's clinical practice.</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Dydrogesterone</mesh_term>
	<criteria>Women aged 16 years or above with menses Patient who is suffering from irregular menstrual cycle for at least 3 months and has been diagnosed as AUBO (irregular cycle is defined as cycle duration ＜ 21days or ＞35 days) Physicians have decided to prescribe dydrogesterone 10mg for cycle regulation treatment, orally taking dydrogesterone 10mg twice daily, from day16 to day 25 of each cycle, being consecutive at least 3 cycles Patient who is willing to sign written authorization Hyperprolactinemia and thyroid dysfunction. Patient took cycle regulation treatment including oral contraceptives, sex hormone or glucocorticoid in the past 1 month Women with estrogen deficiency related symptom Patient who meets the contraindications listed in Chinese label of dydrogesterone Pregnant and lactating patients Patient who is not suitable for the study according to physician's discretion</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>